Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Rheumatology Reviews
  4. Volume 21, Issue 2
  5. Article
Volume 21, Issue 2
  • ISSN: 1573-3971
  • E-ISSN: 1875-6360

Abstract

Cases of systemic lupus erythematosus (SLE) following psoriatic arthritis (PsA) or are uncommon. Due to the complexity of autoimmune diseases and the rarity of such cases, comprehensive global data on the co-occurrence of these conditions are limited. Moreover, the pathophysiology concerning the coexistence of SLE and PsA has yet to be fully understood. Interestingly, the progression of both diseases appears to be significantly influenced by the key interleukin (IL) 17, particularly IL-17A.

Here, we report 7 cases of SLE and PsA coexistence. In 5 of these cases, PsA occurred before the development of SLE, while in the remaining 2 cases, SLE was diagnosed before PsA. The PsA was characterized mainly by peripheral arthritis without any axial involvement, while the manifestations of SLE varied, with 3 developing systematic severe manifestations. Therapeutic challenges were posed in all cases, as treating one condition could worsen the other.

Finally, we review the literature providing the current knowledge on the coexistence of these conditions. Overall, all reported cases emphasize the importance of personalized treatment and careful monitoring for patients with both SLE and PsA.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/crr/10.2174/0115733971294744240530051404
2024-06-13
2025-05-22

  • From This Site

    /content/journals/crr/10.2174/0115733971294744240530051404
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. ZallaM.J. MullerS.A. The coexistence of psoriasis with lupus erythematosus and other photosensitive disorders.Acta Derm. Venereol.19967611510.2340/000155551951158721520
     [Google Scholar]
  2. RobertM. MiossecP. Interleukin-17 and lupus: Enough to be a target? For which patients?Lupus202029161410.1177/096120331989124331791181
     [Google Scholar]
  3. WolfR. Lo SchiavoA. LombardiM.L. PhD De AngelisF. RuoccoV. The in vitro effect of hydroxychloroquine on skin morphology in psoriasis.Int. J. Dermatol.199938215415710.1046/j.1365‑4362.1999.00574.x10192171
     [Google Scholar]
  4. FryL. BakerB.S. Triggering psoriasis: The role of infections and medications.Clin. Dermatol.200725660661510.1016/j.clindermatol.2007.08.01518021899
     [Google Scholar]
  5. WilliamsE.L. GadolaS. EdwardsC.J. Anti-TNF-induced lupus.Rheumatology200948771672010.1093/rheumatology/kep08019416947
     [Google Scholar]
  6. SantosS.C. CastroA.C. MoralesM.C. ÁlvarezD.E. Anti-TNF-α-induced lupus syndrome.Z. Rheumatol.202180548148610.1007/s00393‑021‑00983‑833709168
     [Google Scholar]
  7. VaradaS. GottliebA.B. MerolaJ.F. SaraiyaA.R. TintleS.J. Treatment of coexistent psoriasis and lupus erythematosus.J. Am. Acad. Dermatol.201572225326010.1016/j.jaad.2014.10.03825486913
     [Google Scholar]
  8. AvrielA. ZellerL. FlusserD. ShakraA.M. HalevyS. SukenikS. Coexistence of psoriatic arthritis and systemic lupus erythematosus.Isr. Med. Assoc. J.200791484917274359
     [Google Scholar]
  9. BonillaE. ShadakshariA. PerlA. Association of psoriasis and psoriatic arthritis with systemic lupus erythematosus.Rheumatology and Orthopedic Med.2016111310.15761/ROM.1000105
     [Google Scholar]
  10. TseliosK. YapK.S.Y. PakchotanonR. PolachekA. SuJ. UrowitzM.B. GladmanD.D. Psoriasis in systemic lupus erythematosus: A single-center experience.Clin. Rheumatol.201736487988410.1007/s10067‑017‑3566‑028168661
     [Google Scholar]
  11. GunawanH. AwaliaA. SoerosoJ. The coexistence of systemic lupus erythematosus and psoriasis: Is it possible?Acta Med. Indones.201850214415029950534
     [Google Scholar]
  12. KorkusD. GazittT. CohenA.D. FeldhamerI. LaviI. HaddadA. DotanG.S. BatatE. ZismanD. Increased prevalence of systemic lupus erythematosus comorbidity in patients with psoriatic arthritis: A population-based case-control study.J. Rheumatol.202148220721310.3899/jrheum.19094032414958
     [Google Scholar]
  13. HsiehC.Y. TsaiT.F. Aggravation of discoid lupus erythematosus in a patient with psoriasis and psoriatic arthritis during treatment of secukinumab: A case report and review of literature.Lupus202231789189410.1177/0961203322109569235438595
     [Google Scholar]
  14. SatoK. AizakiY. YoshidaY. MimuraT. Treatment of psoriatic arthritis complicated by systemic lupus erythematosus with the IL-17 blocker secukinumab and an analysis of the serum cytokine profile.Modern Rheumatol Case Reports20204218118510.1080/24725625.2020.171774133086998
     [Google Scholar]
  15. GarelickD. PintoS.M. FarinhaF. PiresT. KhanE. IsenbergD. Fracture risk in systemic lupus erythematosus patients over 28 years.Rheumatology20216062765277210.1093/rheumatology/keaa70533221918
     [Google Scholar]
  16. LiL. XieH. LuN. EsdaileJ.M. ZubietaA.J.A. Impact of systemic lupus erythematosus on the risk of newly diagnosed hip fracture: A general population-based study.Arthritis Care Res.202173225926510.1002/acr.2411231758639
     [Google Scholar]
  17. MillnsJ.L. MullerS.A. The coexistence of psoriasis and lupus erythematosus. An analysis of 27 cases.Arch. Dermatol.1980116665866310.1001/archderm.1980.016403000460157377802
     [Google Scholar]
  18. MazgajM. Picard-DahanC. DeschampsL. MarinhoE. EstèveE. DescampsV. Successful ustekinumab treatment in a patient with psoriasis and subacute cutaneous lupus erythematosus.Int. J. Dermatol.2020594e118e12010.1111/ijd.1477331957866
     [Google Scholar]
  19. McCoyS. NagarajaV. PaviolS. GudjonssonJ.E. KahlenbergJ.M. Exacerbation of psoriasis due to hydroxychloroquine.Arch. Med.2015713
     [Google Scholar]
  20. SatohY. NakanoK. YoshinariH. NakayamadaS. IwataS. KuboS. MiyagawaI. YoshikawaM. MiyazakiY. SaitoK. TanakaY. A case of refractory lupus nephritis complicated by psoriasis vulgaris that was controlled with secukinumab.Lupus20182771202120610.1177/096120331876259829523055
     [Google Scholar]
  21. ZenobiaC. HajishengallisG. Basic biology and role of interleukin-17 in immunity and inflammation.Periodontol. 2000201569114215910.1111/prd.1208326252407
     [Google Scholar]
  22. BlauveltA. ChiricozziA. The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis.Clin. Rev. Allergy Immunol.201855337939010.1007/s12016‑018‑8702‑330109481
     [Google Scholar]
  23. DoreauA. BelotA. BastidJ. RicheB. BiemontT.M.C. RanchinB. FabienN. CochatP. NobleP.C. TrollietP. DurieuI. TebibJ. KassaiB. AnsieauS. PuisieuxA. EliaouJ.F. BérardB.N. Interleukin 17 acts in synergy with B cell–activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus.Nat. Immunol.200910777878510.1038/ni.174119483719
     [Google Scholar]
  24. KogaT. IchinoseK. KawakamiA. TsokosG.C. Current insights and future prospects for targeting IL-17 to treat patients with systemic lupus erythematosus.Front. Immunol.20211162497110.3389/fimmu.2020.62497133597953
     [Google Scholar]
  25. DrososA.A. PelechasE. KaltsonoudisE. MarkatseliT.E. VoulgariP.V. Biologic therapies and autoimmune phenomena.Mediterr. J. Rheumatol.20213229610310.31138/mjr.32.2.9634447904
     [Google Scholar]
  26. VenetsanopoulouA.I. MavridouK. VoulgariP.V. DrososA.A. Cutaneous immune-related phenomena in patients with inflammatory arthritides treated with biological therapies: Clinical and pathophysiological considerations.Semin. Arthritis Rheum.20236315227210.1016/j.semarthrit.2023.15227237788595
     [Google Scholar]
/content/journals/crr/10.2174/0115733971294744240530051404
Loading
Uncommon Coexistence of Systemic Lupus Erythematosus and Psoriatic Arthritis: A Case-Based Review
Curr. Rheumatol. Rev. 21, 116 (2025); https://doi.org/10.2174/0115733971294744240530051404
/content/journals/crr/10.2174/0115733971294744240530051404
/content/journals/crr/10.2174/0115733971294744240530051404
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): autoimmune diseases; coexistence of SLE and PsA; interleukin (IL) 17; psoriasis; psoriatic arthritis; Systemic lupus erythematous

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test